Efentakis, P.; Doerschmann, H.; Witzler, C.; Siemer, S.; Nikolaou, P.-E.; Kastritis, E.; Stauber, R.; Dimopoulos, M.A.; Wenzel, P.; Andreadou, I.;
et al. Investigating the Vascular Toxicity Outcomes of the Irreversible Proteasome Inhibitor Carfilzomib. Int. J. Mol. Sci. 2020, 21, 5185.
https://doi.org/10.3390/ijms21155185
AMA Style
Efentakis P, Doerschmann H, Witzler C, Siemer S, Nikolaou P-E, Kastritis E, Stauber R, Dimopoulos MA, Wenzel P, Andreadou I,
et al. Investigating the Vascular Toxicity Outcomes of the Irreversible Proteasome Inhibitor Carfilzomib. International Journal of Molecular Sciences. 2020; 21(15):5185.
https://doi.org/10.3390/ijms21155185
Chicago/Turabian Style
Efentakis, Panagiotis, Hendrik Doerschmann, Claudius Witzler, Svenja Siemer, Panagiota-Efstathia Nikolaou, Efstathios Kastritis, Roland Stauber, Meletios Athanasios Dimopoulos, Philip Wenzel, Ioanna Andreadou,
and et al. 2020. "Investigating the Vascular Toxicity Outcomes of the Irreversible Proteasome Inhibitor Carfilzomib" International Journal of Molecular Sciences 21, no. 15: 5185.
https://doi.org/10.3390/ijms21155185
APA Style
Efentakis, P., Doerschmann, H., Witzler, C., Siemer, S., Nikolaou, P.-E., Kastritis, E., Stauber, R., Dimopoulos, M. A., Wenzel, P., Andreadou, I., & Terpos, E.
(2020). Investigating the Vascular Toxicity Outcomes of the Irreversible Proteasome Inhibitor Carfilzomib. International Journal of Molecular Sciences, 21(15), 5185.
https://doi.org/10.3390/ijms21155185